V8 Peptides — Engineered Performance

Research Library

Peptide Research, Explained

Evergreen guides on purity, documentation, handling, and the compounds themselves — written as research and procurement education. For laboratory research use only.

Sermorelin Preclinical Research: Animal Model Map
SermorelinPreclinical

Sermorelin Preclinical Research: Animal Model Map

A map of the animal and ex vivo models used with GHRH peptides, tied to the molecule each study actually tested.

Read article →
Sermorelin In Vitro: Pituitary Cell Assay Models
SermorelinPreclinical

Sermorelin In Vitro: Pituitary Cell Assay Models

What the in vitro literature on GHRH (1-29) peptides reports: cell systems, readouts, controls, concentration conversions and the limits of IGF-1 readouts.

Read article →
AOD-9604 Preclinical Literature: Study by Study
AOD-9604Preclinical

AOD-9604 Preclinical Literature: Study by Study

A study-by-study appraisal of AOD-9604 preclinical papers, with models, findings, limitations and gaps in the evidence.

Read article →
Workout Recovery: What the Evidence Shows by Strategy
Research CompoundsPreclinical

Workout Recovery: What the Evidence Shows by Strategy

A strategy-by-strategy look at what meta-analyses and trials report about post-exercise recovery: soreness, muscle-damage markers, inflammation and training adaptation, and where the evidence is thin or mixed.

Read article →
Why Sexual Desire Declines With Age: What Studies Report
Research CompoundsPreclinical

Why Sexual Desire Declines With Age: What Studies Report

A literature-based explainer on age and sexual desire: what large surveys measured, which hormone trends were documented, how psychosocial factors compare, and how researchers study desire circuits in animal models.

Read article →
Why Peptides Matter in Biomedical Research
Research CompoundsPreclinical

Why Peptides Matter in Biomedical Research

A literature-based look at why peptides matter in research: their selectivity, their origin in hormone biology, the chemistry used to improve them, and the practical problems researchers face in the laboratory.

Read article →
Nootropic Peptides: Semax and Selank Evidence Map
SelankPreclinical

Nootropic Peptides: Semax and Selank Evidence Map

A research-literature map for Semax and Selank: parent fragments, the BDNF and GABA-gene studies, readouts by question, controls, and the limits of the evidence.

Read article →
Tesamorelin Clinical Literature: A Bench-Scientist Guide
TesamorelinPreclinical

Tesamorelin Clinical Literature: A Bench-Scientist Guide

A guide to the published tesamorelin trial abstracts for laboratory readers: design, endpoints, responder analyses and limits. No doses.

Read article →
TB-500 Muscle and Ligament Animal Studies: Endpoints
TB-500Preclinical

TB-500 Muscle and Ligament Animal Studies: Endpoints

A methods-focused read of the musculoskeletal animal studies behind TB-500 claims: molecule, route, time point and endpoint class.

Read article →
TB-500 Mechanism: When Thymosin β4 Knockouts Disagree
TB-500Preclinical

TB-500 Mechanism: When Thymosin β4 Knockouts Disagree

Two Nature papers and a 2012 knockout study give conflicting answers on thymosin β4 in the heart. What that means for TB-500 experiments.

Read article →
GHK-Cu and BPC-157 Skin Repair Models Compared
GHK-CuPreclinical

GHK-Cu and BPC-157 Skin Repair Models Compared

A side-by-side map of the published skin and wound models for GHK-Cu and BPC-157, with systems, readouts, vehicle controls and evidence limits.

Read article →
Retatrutide Side Effects: What Preclinical Studies Report
RetatrutidePreclinical

Retatrutide Side Effects: What Preclinical Studies Report

What published preclinical studies and a trial abstract report about gastrointestinal, thyroid and cardiovascular signals for triple-agonist peptides, with limits stated.

Read article →
Sermorelin Half-Life: What Published Studies Measured
SermorelinPreclinical

Sermorelin Half-Life: What Published Studies Measured

Four different half-life quantities for GHRH (1-29) explained: plasma, in vivo, culture medium and vial, with the studies behind each.

Read article →
Semax in Animal Models: A Model Selection Guide
SemaxPreclinical

Semax in Animal Models: A Model Selection Guide

Semax has been studied in ischemia, spinal cord injury, stress and development models in rats. This guide helps a lab choose among them by question, endpoint and limitation.

Read article →
Semax Intranasal Route in Preclinical Research Studies
SemaxPreclinical

Semax Intranasal Route in Preclinical Research Studies

A literature guide to the intranasal route in published Semax animal studies, with the amounts and schedules as reported and the arithmetic for converting them into a laboratory stock.

Read article →
Semax Cognitive Function Research: Rodent Behavior Models
SemaxPreclinical

Semax Cognitive Function Research: Rodent Behavior Models

A reader's guide to the behavioral tests used in published Semax work: passive avoidance, conditioned avoidance, sucrose preference and anxiety models, with what each did and did not show.

Read article →
Semaglutide Cardiovascular Research: Preclinical Models
SemaglutidePreclinical

Semaglutide Cardiovascular Research: Preclinical Models

How preclinical semaglutide vascular studies are designed, what the mouse and receptor-localization data show, and where they stop.

Read article →
Semaglutide Animal Models: Choosing a Species
SemaglutidePreclinical

Semaglutide Animal Models: Choosing a Species

A question-first guide to species and model selection in published semaglutide animal studies, with cross-species caveats.

Read article →
Semaglutide Research Update: 2025–2026 Preclinical Papers
SemaglutidePreclinical

Semaglutide Research Update: 2025–2026 Preclinical Papers

A neutral reading guide to 2025–2026 semaglutide preclinical papers and what each means for a research laboratory.

Read article →
Selank Research Peptide: What the Evidence Shows
SelankPreclinical

Selank Research Peptide: What the Evidence Shows

An evidence map for Selank: five tiers of preclinical data, how to word each finding, and what remains unresolved.

Read article →
Selank Anxiolytic Peptide Research: Models and Readouts
SelankPreclinical

Selank Anxiolytic Peptide Research: Models and Readouts

How rodent anxiety models, strain differences and molecular readouts shape what Selank studies can and cannot show.

Read article →
Selank in Animal Models: Preclinical Findings Reviewed
SelankPreclinical

Selank in Animal Models: Preclinical Findings Reviewed

What published animal and tissue studies report about Selank: gene-expression panels, a morphine-withdrawal rat model, spleen inflammation genes and the limits of the evidence.

Read article →
AOD-9604 in Rodent Models: Obese Mice and Zucker Rats
AOD-9604Preclinical

AOD-9604 in Rodent Models: Obese Mice and Zucker Rats

A model-by-model reading of the published rodent studies on AOD-9604, the hGH 176-191 fragment: designs, reported results, controls and limits.

Read article →
Cagrilintide Half-Life and Preclinical Pharmacokinetics
CagrilintidePreclinical

Cagrilintide Half-Life and Preclinical Pharmacokinetics

A research explainer on cagrilintide pharmacokinetics: what half-life means, albumin binding by lipidation, bioanalysis design, and formula-only stock concentration math.

Read article →

84 articles in Preclinical